BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

SN Bioscience Secures US FDA Orphan Drug Designation For SNB 101 In Gastric Cancer

SN Bioscience Inc. (CEO Young Hwan PARK) announced that the FDA had granted Orphan Drug Designation (ODD) on December 10 for gastric cancer (incl...

December 25, 2025 | News

GC Biopharma Secures MFDS Approval For Phase 1 Trial Of mRNA Covid 19 Vaccine Candidate

Phase 2 IND submission targeted for the second half of 2026- Demonstrating the competitiveness of GC Biopharma's mRNA platform GC Biopharma (...

December 24, 2025 | News

Samsung Biologics Acquires GSK Rockville Facility To Establish First US Manufacturing Site

- Secures the company’s first U.S.-based manufacturing site, strengthening and diversifying its global supply network - Additional investments plann...

December 22, 2025 | News

MEDI&GENE Enters Catalyze Agreement With Eli Lilly To Advance Next Generation Obesity Therapy

MEDI&GENE, a biopharmaceutical company developing therapeutics for metabolic diseases, announced today that it has entered into a Catalyze agreeme...

December 19, 2025 | News

Galux Partners With Boehringer Ingelheim To Advance AI Driven Precision Protein Design

-Galux, a South Korean biotech pioneering AI-driven protein therapeutics discovery, announced that it has signed a research agreement with Boehr...

December 19, 2025 | News

Celltrion Secures Positive CHMP Opinion For SteQeyma Autoinjector In Europe

SteQeyma™ 45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcu...

December 19, 2025 | News

Pixelgen Expands Asia Pacific Footprint With South Korea Distribution Agreement

- Pixelgen Technologies, Inc. and MDxK (Molecular Diagnostics Korea) Inc., part of DKSH Business Unit Technology, a leader in market expansion se...

December 16, 2025 | News

Rhinocare Korea Sets Up Singapore Joint Venture To Drive Global Expansion In Drug Free Respiratory Care

Rhinocare Korea, a medtech innovator specializing in drug-free respiratory care, announced plans to establish a joint venture (JV) in Singapore a...

December 12, 2025 | News

South Korea Takes A Major Step Toward Blood Based Alzheimer’s Diagnosis With Simoa Platform Approval

Quanterix Corporation (NASDAQ: QTRX), a U.S.-based biotechnology company specializing in ultrasensitive biomarker detection, and its clinical diagnostics b...

December 12, 2025 | News

South Korea Scientists Introduce MUTE Seq For Ultra Sensitive Cancer Mutation Detection In Liquid Biopsy

MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches acros...

December 10, 2025 | News

GC Biopharma Ships World First Recombinant Anthrax Vaccine For National Stockpile

GC Biopharma (006280.KS), a leading global biopharmaceutical company, announced the first shipment of BARYTHRAX inj., the world's first recombinant a...

December 09, 2025 | News

Lunit Submits FDA 510k For AI Driven Five Year Breast Cancer Risk Prediction Model

Submission marks a key regulatory milestone toward bringing SEER-calibrated, imaging-based risk assessment to U.S. screening programs Lunit (KRX:328130), ...

December 09, 2025 | News

AGC Biologics Strengthens Global Cell Line Capabilities With ATUM Partnership and Leap In Technology

New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex mole...

December 04, 2025 | News

Ajinomoto CELLiST Korea Launches New CELLiST AAV Production Supplement 1 to Boost Viral Vector Productivity

Ajinomoto Co in Tokyo collaborated with its United States based consolidated subsidiary Forge Biologics, a leading CDMO in adeno associated virus developme...

December 04, 2025 | News

Stay Connected